Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
50,806,897
-
Shares change
-
+2,446,084
-
Total reported value, excl. options
-
$2,032,970,440
-
Value change
-
+$95,437,423
-
Put/Call ratio
-
195%
-
Number of buys
-
124
-
Number of sells
-
-136
-
Price
-
$40.00
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2017
316 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2017.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,806,897 shares
of 56,047,431 outstanding shares and own 91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,781,836 shares), VANGUARD GROUP INC (4,489,064 shares), Invesco Ltd. (2,062,652 shares), Bank of New York Mellon Corp (1,483,043 shares), STATE STREET CORP (1,410,379 shares), DIMENSIONAL FUND ADVISORS LP (1,267,424 shares), ACADIAN ASSET MANAGEMENT LLC (1,255,688 shares), Champlain Investment Partners, LLC (1,229,975 shares), RICE HALL JAMES & ASSOCIATES, LLC (1,224,317 shares), and ROTHSCHILD ASSET MANAGEMENT INC (1,127,218 shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.